Searched for
CHLORTHALIDONE TABLETS
FDA recalls blood pressure medication: Reason, affected drugs, and should you stop taking the pills?The FDA has urgently recalled more than 25,000 bottles of Chlorthalidone tablets from Inventia Healthcare. This recall is prompted by failu...- FDA Chlorthalidone dissolution testing recall: More than 25,000 bottles of blood pressure medication recalled. Check which tablets are impacted?Blood Pressure tablets FDA chlorthalidone dissolution testing recall: Chlorthalidone medication is prescribed to keep the blood pressure in...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Pharma stocks: Moving from ‘What if’ to ‘Maybe not’. 8 pharma stocks, 3 with upside potential above 22%; others not so high, but…There are two ways to look at the hope which the street is reflecting when it comes to a possible India-US tariff deal. One, it will bring ...
- Pharma sector: Reasons to look at it beyond the tariff exemption. 7 pharma stocks with an upside potential of up to 43%Along with semiconductors, electronics and IT, pharma is another sector exempt from the Trump tariffs. Still, as the broader indices declin...
- They fall, you catch. One might be a winner in the long term: 8 pharma stocks with upside potential of over 35%Given that the headlines are dominated by what is happening at the border, the street may be forgiven for not noting developments that matt...
- Necessary pill for portfolio during volatility and Trump tariff wars: 8 pharma stocks with an upside potential of up to 48%Let’s accept the fact that we are likely to be dealing with volatility for the next four years. Both in the real world and in the global an...
- A Trump tariff tantrum-proof sector? 8 stocks from pharma sector, where Democrats and Republicans are in agreement, with an upside potential of up to 34% in 1 yearWhen Donald Trump is back in the saddle, one thing is certain: Tariff wars. Yes, China will be the biggest target. But for all those who th...
- Alpha generators in the long term: 9 mid and small cap stocks from pharma and healthcare sector with an upside potential of up to 29%While some make it to the headlines, some don't. Two sectors, healthcare and pharma have been witnessing more mergers and acquisitions than...
- These healthcare and pharma stocks may deliver more than 20% in one yearCheck out Stock Reports Plus, powered by Refinitiv, for price targets of over 4,000 listed stocks along with detailed company analysis focu...
- For all market conditions: 5 largecap stocks from different sectors with upside potential of up to 33%The US interest rates and yields are one of the most important drivers of liquidity in global markets. That is the reason at the first hint...
- NPPA fixes retail prices of 23 drug formulationsSimilarly, the retail price of one tablet of Telmisartan, Chlorthalidone & Cilnidipine tablets at Rs 13.17. The retail price of one tablet ...
- Nifty healthcare index stocks analysts suggest buying have potential upside of more than 19%Except for a pocket in which demand for covid drugs led to sharp surge in pharma stocks, the pharma sector had been under pressure for a lo...
- Sun Pharma, Aurobindo slide up to 2% as firms recall products in US marketAurobindo’s scrip fell to a low of Rs 612.60, 2 per cent lower than previous close on the National Stock Exchange, while Sun Pharma’s count...
- Aurobindo, Sun Pharma recall products in US marketAccording to the latest enforcement report issued by the US Food and Drug Administration (USFDA), the US-based arm of Aurobindo Pharma is r...
- Stocks in the news: RIL, Sun Pharma, ONGC, Natco Pharma and Tata MotorsReliance Powerreported 80 per cent decline in its consolidated net profit in June quarter.
- Unichem Laboratories gets USFDA nod for hypertension management drugThe approved product is a generic version of Hygroton tablets, 25 mg and 50 mg of Sanofi Aventis US, LLC.
- Zydus Cadila gets USFDA nod for blood pressure lowering drugZydus Cadila has received the final approval from the United States Food and Drug Administration to market Chlorthalidone tablets.
- Key diabetes, anti-cancer drugs among 92 in price-ceiling listThe National Pharmaceutical Pricing Authority said in orders dated August 13 that manufacturers of these drugs will fix their retail prices...
- NPPA fixes retail prices of 14 formulationsDrug price regulator has also asked manufacturers to furnish quarterly return regarding production, import and sale of their products.
Load More
